USANA Health Sciences Inc Cash Flow-to-Debt Ratio
USANA Health Sciences Inc cash flow-to-debt ratio. USANA Health Sciences Inc (USNA) has a Cash Flow-to-Debt Ratio of 0.07x as of March 2026, meaning its operating cash flow of $9.76 Million could theoretically repay 0% of its total liabilities ($144.18 Million) in one year. Check USNA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of USANA Health Sciences Inc (1995–2025)
Cash flow-to-debt ratio of USANA Health Sciences Inc from 1995 to 2025. Historical debt coverage capacity for USANA Health Sciences Inc across 31 annual periods. Check USANA Health Sciences Inc (USNA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
USANA Health Sciences Inc Cash Flow-to-Debt Ratio by Year (1995–2025)
USANA Health Sciences Inc cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for USANA Health Sciences Inc. For the full cash flow conversion analysis, see USNA cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $22.35 Million | $156.64 Million | ▼ -62.1% |
| 2024 | 0.38x | $60.99 Million | $161.86 Million | ▼ -27.7% |
| 2023 | 0.52x | $70.64 Million | $135.56 Million | ▼ -18.7% |
| 2022 | 0.64x | $103.90 Million | $162.08 Million | ▼ -3.4% |
| 2021 | 0.66x | $121.23 Million | $182.62 Million | ▼ -17.5% |
| 2020 | 0.81x | $160.40 Million | $199.24 Million | ▲ +5.0% |
| 2019 | 0.77x | $126.73 Million | $165.22 Million | ▼ -17.6% |
| 2018 | 0.93x | $152.12 Million | $163.32 Million | ▲ +17.4% |
| 2017 | 0.79x | $123.78 Million | $156.06 Million | ▼ -15.9% |
| 2016 | 0.94x | $137.03 Million | $145.35 Million | ▲ +20.4% |
| 2015 | 0.78x | $111.47 Million | $142.38 Million | ▼ -10.4% |
| 2014 | 0.87x | $105.19 Million | $120.42 Million | ▼ -4.7% |
| 2013 | 0.92x | $98.89 Million | $107.95 Million | ▼ -19.3% |
| 2012 | 1.13x | $92.81 Million | $81.78 Million | ▲ +14.3% |
| 2011 | 0.99x | $70.11 Million | $70.59 Million | ▼ -11.9% |
| 2010 | 1.13x | $66.11 Million | $58.64 Million | ▲ +70.4% |
| 2009 | 0.66x | $32.47 Million | $49.06 Million | ▲ +30.7% |
| 2008 | 0.51x | $45.96 Million | $90.74 Million | ▼ -37.6% |
| 2007 | 0.81x | $57.22 Million | $70.49 Million | ▼ -46.6% |
| 2006 | 1.52x | $60.52 Million | $39.80 Million | ▼ -11.4% |
| 2005 | 1.72x | $48.02 Million | $27.97 Million | ▲ +7.1% |
| 2004 | 1.60x | $38.18 Million | $23.82 Million | ▼ -6.2% |
| 2003 | 1.71x | $35.48 Million | $20.76 Million | ▲ +125.4% |
| 2002 | 0.76x | $15.94 Million | $21.02 Million | ▲ +58.7% |
| 2001 | 0.48x | $9.95 Million | $20.83 Million | ▲ +165.7% |
| 2000 | 0.18x | $4.07 Million | $22.62 Million | ▼ -71.3% |
| 1999 | 0.63x | $15.00 Million | $23.90 Million | ▼ -44.3% |
| 1998 | 1.13x | $10.60 Million | $9.40 Million | ▲ +12.8% |
| 1997 | 1.00x | $7.10 Million | $7.10 Million | ▲ +107.1% |
| 1996 | 0.48x | $4.20 Million | $8.70 Million | ▼ -55.4% |
| 1995 | 1.08x | $3.90 Million | $3.60 Million | — |